Hypomelanotic Disorder Latest Advances

Intralesional Vitamin D in Dermatology: An Evidence-Based Review of Utility.

Journal: Indian journal of dermatology

Published: September 08, 2026

The Potency of Artificial Intelligence in Diagnosing and Evaluating the Severity of Vitiligo: A Systematic Review and Meta-Analysis.

Journal: Indian journal of dermatology

Published: September 08, 2026

Genetic and functional characterization of a novel KIT splicing variant in a Chinese three-generation pedigree with piebaldism

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Published: September 07, 2026

Pharmacological solutions for vitiligo: emerging role of Janus kinase inhibitors.

Journal: Expert opinion on pharmacotherapy

Published: September 07, 2026

Uniform repigmentation following difamilast treatment for vitiligo.

Journal: European journal of dermatology : EJD

Published: September 06, 2026

Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo.

Journal: The Journal of dermatological treatment

Published: September 02, 2026

Leukotrichia: A comprehensive review of follicular depigmentation.

Journal: The Journal of international medical research

Published: September 01, 2026

Peripheral predominance of facial idiopathic guttate hypomelanosis in a retrospective observational study: A clinical clue to distinguish from vitiligo.

Journal: JAAD international

Published: August 30, 2026

Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials.

Journal: The Journal of dermatological treatment

Published: August 28, 2026

Homozygous 11q14.3 deletion causing oculocutaneous albinism and multisystem disorder.

Journal: BMJ case reports

Published: August 28, 2026

Mild form of aromatic L-amino acid decarboxylase deficiency.

Journal: BMJ case reports

Published: August 26, 2026

Harmonising vitiligo outcomes: why global context matters.

Journal: The British journal of dermatology

Published: August 19, 2026

Hypomelanotic Disorder Latest Advances

Find the Latest Research About Hypomelanotic Disorder

Intralesional Vitamin D in Dermatology: An Evidence-Based Review of Utility.

Intralesional Vitamin D in Dermatology: An Evidence-Based Review of Utility.

The Potency of Artificial Intelligence in Diagnosing and Evaluating the Severity of Vitiligo: A Systematic Review and Meta-Analysis.

The Potency of Artificial Intelligence in Diagnosing and Evaluating the Severity of Vitiligo: A Systematic Review and Meta-Analysis.

Genetic and functional characterization of a novel KIT splicing variant in a Chinese three-generation pedigree with piebaldism

Genetic and functional characterization of a novel KIT splicing variant in a Chinese three-generation pedigree with piebaldism

Pharmacological solutions for vitiligo: emerging role of Janus kinase inhibitors.

Pharmacological solutions for vitiligo: emerging role of Janus kinase inhibitors.

Uniform repigmentation following difamilast treatment for vitiligo.

Uniform repigmentation following difamilast treatment for vitiligo.

Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo.

Development of items to assess noticeability and sun sensitivity among patients with non-segmental vitiligo.

Leukotrichia: A comprehensive review of follicular depigmentation.

Leukotrichia: A comprehensive review of follicular depigmentation.

Peripheral predominance of facial idiopathic guttate hypomelanosis in a retrospective observational study: A clinical clue to distinguish from vitiligo.

Peripheral predominance of facial idiopathic guttate hypomelanosis in a retrospective observational study: A clinical clue to distinguish from vitiligo.

Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of JAK inhibitors for vitiligo: an updated systematic review and meta-analysis of randomized controlled trials.

Homozygous 11q14.3 deletion causing oculocutaneous albinism and multisystem disorder.

Homozygous 11q14.3 deletion causing oculocutaneous albinism and multisystem disorder.

Mild form of aromatic L-amino acid decarboxylase deficiency.

Mild form of aromatic L-amino acid decarboxylase deficiency.

Harmonising vitiligo outcomes: why global context matters.

Harmonising vitiligo outcomes: why global context matters.